InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"

NEWS
Publication
August 19, 2025

The new article “Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology” by Igor Goryanin, Irina Goryanin, Oleg Demin was published in Drug Discovery Today on August 6, 2025.

Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, highlights, "AI is a hot topic now. QSP was “on hype” previously but now is (almost) routinely applied in drug development. In the paper we are discussing possible ways of their combination. We do not know which ideas mentioned in our paper will be implemented in current QSP framework and how they are able to modify/improve/simplify an application of QSP models. But we think that attempts to implement the ideas in the real QSP modeling efforts is even more important than participation in the AI vs QSP discussions. I would like to acknowledge Igor Goryanin who is first and key author of the paper for his initiative to write the paper and enourmous efforts and enthusiasm!"

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

 

July 2020
MoTuWeThFrSaSu
  
1
2
3
4
5
6
1. 06 Jul 2020 17:37 InSysBio to announce the launch of its new tool Heta compiler Heta compiler has been published on GitHub as an OpenSource (Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
1. 27 Jul 2020 11:45 InSysBio to evolve its Open Source QSP model of COVID-19 InSysBio has presented a new portion of results in the framework of development of COVID-19 QSP model.
2. 27 Jul 2020 16:42 InSysBio to present its posters at AAIC 2020 Virtual Event InSysBio announces its participation in AAIC 2020 Virtual Event. Alzheimer's Association International Conference is held virtually on July 27-31. InSysBio team presents two posters within its frames
28
29
30
31
  
Upcoming Events
07.04
InSysBio to hold a workshop on Heta at QSPC 2026
08.04
InSysBio to participate in QSPC 2026
Tags
Latest News
28.01
InSysBio to announce a new collaborative project with BeOne Medicines
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling